AtriCure Inc (NASDAQ:ATRC) — Market Cap & Net Worth
Market Cap & Net Worth: AtriCure Inc (ATRC)
AtriCure Inc (NASDAQ:ATRC) has a market capitalization of $1.37 Billion ($1.37 Billion) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #7744 globally and #2246 in its home market, demonstrating a -0.66% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AtriCure Inc's stock price $27.12 by its total outstanding shares 50640970 (50.64 Million). Review ATRC liabilities breakdown to assess the company's total debt and financial obligations.
AtriCure Inc Market Cap History: 2015 to 2026
AtriCure Inc's market capitalization history from 2015 to 2026. Data shows growth from $1.14 Billion to $1.37 Billion (3.29% CAGR).
Index Memberships
AtriCure Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.06% | #215 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #830 of 3165 |
Weight: AtriCure Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
AtriCure Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AtriCure Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.75x
AtriCure Inc's market cap is 3.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $991.04 Million | $155.11 Million | -$33.34 Million | 6.39x | N/A |
| 2017 | $923.69 Million | $174.72 Million | -$26.89 Million | 5.29x | N/A |
| 2018 | $1.55 Billion | $201.63 Million | -$21.14 Million | 7.69x | N/A |
| 2019 | $1.65 Billion | $230.81 Million | -$35.19 Million | 7.13x | N/A |
| 2020 | $2.82 Billion | $206.53 Million | -$48.16 Million | 13.65x | N/A |
| 2021 | $3.52 Billion | $274.33 Million | $50.20 Million | 12.84x | 70.14x |
| 2022 | $2.25 Billion | $330.38 Million | -$46.47 Million | 6.80x | N/A |
| 2023 | $1.81 Billion | $399.25 Million | -$30.44 Million | 4.53x | N/A |
| 2024 | $1.55 Billion | $465.31 Million | -$44.70 Million | 3.33x | N/A |
| 2025 | $2.00 Billion | $534.53 Million | -$11.45 Million | 3.75x | N/A |
Competitor Companies of ATRC by Market Capitalization
Companies near AtriCure Inc in the global market cap rankings as of June 18, 2026.
Key companies related to AtriCure Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #164 globally with a market cap of $142.44 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #267 globally with a market cap of $94.60 Billion USD ( €80.92 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #340 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #542 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #164 | Intuitive Surgical Inc | NASDAQ:ISRG | $142.44 Billion | $402.18 |
| #267 | EssilorLuxottica S. A. | PA:EL | $94.60 Billion | €174.75 |
| #340 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €91.50 |
| #542 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
AtriCure Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, AtriCure Inc's market cap moved from $1.14 Billion to $ 1.37 Billion, with a yearly change of 3.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.37 Billion | -31.45% |
| 2025 | $2.00 Billion | +29.45% |
| 2024 | $1.55 Billion | -14.37% |
| 2023 | $1.81 Billion | -19.58% |
| 2022 | $2.25 Billion | -36.17% |
| 2021 | $3.52 Billion | +24.90% |
| 2020 | $2.82 Billion | +71.24% |
| 2019 | $1.65 Billion | +6.24% |
| 2018 | $1.55 Billion | +67.76% |
| 2017 | $923.69 Million | -6.80% |
| 2016 | $991.04 Million | -12.79% |
| 2015 | $1.14 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of AtriCure Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.37 Billion USD |
| MoneyControl | $1.37 Billion USD |
| MarketWatch | $1.37 Billion USD |
| marketcap.company | $1.37 Billion USD |
| Reuters | $1.37 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About AtriCure Inc
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; m… Read more